Oxford Biomedica annual r&d spending
2020
2021
2022
2023
2024
2025
Oxford Biomedica R&D Spending Growth & History (OXB)
Oxford Biomedica's r&d spending was £5.1M for fiscal 2025.
View full Oxford Biomedica company overviewOxford Biomedica annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | £5.1M | £518,000 | +11.40% |
| 2024 | 2024-12-31 | £4.5M | −£6.9M | −60.39% |
| 2023 | 2023-12-31 | £11.5M | −£49.5M | −81.18% |
| 2022 | 2022-12-31 | £60.9M | £20.7M | +51.63% |
| 2021 | 2021-12-31 | £40.2M | £10.4M | +35.09% |
| 2020 | 2020-12-31 | £29.7M | — | — |
Oxford Biomedica r&d spending trends
Over the last five fiscal years, Oxford Biomedica's r&d spending decreased from £29.7M to £5.1M, a change of −£24.7M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
reported R&D expense
TickerStat standardizes research and development expense reported in company official filings, including the software-specific standardized R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oxford Biomedica source filings ↗